<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> caused by various neoplastic and primary <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow diseases</z:e> are susceptible to major <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>There are few reports addressing the incidence and outcome of gastrointestinal (GI) <z:mp ids='MP_0001914'>bleeding</z:mp> in patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> characterized by long-standing <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to retrospectively determine the incidence, etiology, clinical outcomes, and risk factors associated with overt GI <z:mp ids='MP_0001914'>bleeding</z:mp> in patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We analyzed the medical records of 508 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> after excluding patients below 15 years of age or those who underwent stem cell transplantation between January 1, 2002, and December 31, 2007 </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 32 patients developed overt GI <z:mp ids='MP_0001914'>bleeding</z:mp> during this period </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated the site, etiology, outcomes, and major risk factors in these patients who developed GI <z:mp ids='MP_0001914'>bleeding</z:mp> episodes </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of GI <z:mp ids='MP_0001914'>bleeding</z:mp> was 6.3% (32 of 508 patients) in adult patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence increased to 12.6% (28 of 222 patients) in patients with severe disease </plain></SENT>
<SENT sid="8" pm="."><plain>One patient died from massive GI <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> sites included the esophagus (two patients, 6.3%), stomach (five, 16.3%), duodenum (two, 6.3%), small intestine (five, 15.6%), large intestine (seven, 21.6%), and unknown site (11, 34.4%) </plain></SENT>
<SENT sid="10" pm="."><plain>Lower GI bleeds mainly caused by neutropenic <z:hpo ids='HP_0004387'>enterocolitis</z:hpo> (NEC) and solitary <z:mpath ids='MPATH_579'>ulcer</z:mpath> developed more frequently than upper GI bleeds </plain></SENT>
<SENT sid="11" pm="."><plain>The major risk factors for GI <z:mp ids='MP_0001914'>bleeding</z:mp> included old age (P = 0.004, odds ratio (OR) = 1.039), severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (P &lt; 0.001, OR = 11.934), non-response to therapy (P = 0.001, OR = 5.652), and major <z:mp ids='MP_0001914'>bleeding</z:mp> history in another organ (P &lt; 0.001, OR = 6.677) </plain></SENT>
<SENT sid="12" pm="."><plain>Overt GI <z:mp ids='MP_0001914'>bleeding</z:mp> in patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> more frequently develops in the lower tract than in the upper tract </plain></SENT>
<SENT sid="13" pm="."><plain>The risk of GI <z:mp ids='MP_0001914'>bleeding</z:mp> is higher in patients with the following risk factors: older age, severe disease, poor response to treatment, and major <z:mp ids='MP_0001914'>bleeding</z:mp> history in another organ </plain></SENT>
</text></document>